Trial · NCT03412513
Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease
NCT03412513, Phase 4, Unknown, Seoul National University Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease. Trials, record NCT03412513. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03412513
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease
- NCT number
- NCT03412513
- Status
- Unknown
- Phases
- Phase 4
- Enrollment
- 144 participants, estimated
- Lead sponsor
- Seoul National University Hospital
- Conditions
- Overactive Bladder, Parkinson Disease
- Interventions
- Mirabegron, Placebo
- First posted
- 2018-01-26
- Last updated
- 2018-01-30
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in the total score of Overactive Bladder Symptom Scale(OABSS) | Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2) | Change in the total score of Overactive Bladder Symptom Scale(OABSS) from baseline(Visit 2) to Visit 4 |
| Secondary | Change in the total score of OABSS(Overactive Bladder Symptom Scale) | Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2) | Change in the total score of OABSS, Visit 3, Visit 4 and Visit 5 |
| Secondary | Change in the total score of IPSS(International Prostate Symptom Score) | Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2) | Change in the total score of IPSS and bothersome score, Visit 3, Visit 4 and Visit 5 |
| Secondary | Change in the total score of OAB-q short form | Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2) | Change in the total score of OAB-q short form,Visit 3, Visit 4 and Visit 5 |
| Secondary | Change in the total score of PPBC(Patient Perception of Bladder Condition) | Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2) | Change in the total score of PPBC, Visit 3, Visit 4 and Visit 5 |
| Secondary | Change in the total score of TSQ (Treatment Satisfaction Questionnaire) | Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2) | Change in the total score of TSQ, Visit 3, Visit 4 and Visit 5 |
| Secondary | Change in the total score of GRA (Global Response Assessment) | Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2) | Change in the total score of GRA, Visit 3, Visit 4 and Visit 5 |
| Secondary | Change in the score of BSW (Benefit, Satisfaction and Willingness to Continue Questions) | Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2) | Change in the score of BSW, Visit 4 and Visit 5 |
| Secondary | Change in the Mean Frequent Urination | Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2) | Change in the Mean Frequent Urination, Visit 3 and Visit 4 |
| Secondary | Change in the Mean number of Urinary urgency | Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2) | Change in the Mean number of Urinary urgency, Visit 3 and Visit 4 |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03412513
GET https://conductscience.org/api/trials/v1/NCT03412513/registered